Beijing Mabworks Biotech Co., Ltd.   Report issue

For profit Phase 1 Phase 3
Founded: Beijing China (2003)

Organization Overview

First Clinical Trial
2017
NCT04103905
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Beijing Mabworks Biotech Co., Ltd.